Inventor · Lake Forest Park, WA, US

Katherine E. Lewis

19Patents
8h-index
36Co-inventors
68Inventor score

Filing activity: Oct 7, 2003 → Sep 11, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US7910703B2 Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use Emerging Cross-Sectional Technologies 38 Active
US7790862B2 IL-17 and IL-23 antagonists and methods of using the same Chemistry; Metallurgy 34 Active
US8822642B2 Dimeric fusion proteins and related compositions and methods Chemistry; Metallurgy 27 Active
US8333968B2 Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19 Emerging Cross-Sectional Technologies 26 Active
US9765147B2 Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer Chemistry; Metallurgy 17 Active
US8496936B2 Antagonists of IL-17A, IL-17F, and IL-23P19 Emerging Cross-Sectional Technologies 15 Active
US10081681B2 Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors Chemistry; Metallurgy 10 Active
US8227579B2 IL-23 antagonists Chemistry; Metallurgy 8 Active
US7291589B2 Uses of human Zven proteins and polynucleotides Physics 6 Expired
US10221244B2 Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer Chemistry; Metallurgy 5 Active
US8992922B2 Antagonists of IL-17A, IL-17F, and IL-23P19 Emerging Cross-Sectional Technologies 5 Active
US11274152B2 Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors Chemistry; Metallurgy 3 Active
US10618967B2 Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer Chemistry; Metallurgy 2 Active
US9464134B2 Polynucleotides encoding antagonists of IL-17A, IL-17F, and IL-23p19 Emerging Cross-Sectional Technologies 1 Active
US9994634B2 Use of an IL-17/IL-23 bispecific antibody for treating inflammation Emerging Cross-Sectional Technologies 0 Active
US11566076B2 Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers Chemistry; Metallurgy 0 Active
US7592312B2 Methods of modulating gastrointestinal contractility Physics 0 Active
US10562967B2 Treating inflammation with IL-17/IL-23 bispecific antibodies Emerging Cross-Sectional Technologies 0 Active
US11421034B2 Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.